FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/065878 [Registered on: 18/04/2024] Trial Registered Prospectively
Last Modified On: 22/02/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Efficacy of Haritaki Churna in Prediabetes 
Scientific Title of Study   Efficacy of Haritaki churna in Prediabetes-A Double-Blind Randomized Controlled Clinical Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Patil Shraddha Anilrao 
Designation  PG Scholar Department Of Rasayana Evum Vajikarana 
Affiliation  KAHERs Shri B M Kankanwadi Ayurveda Mahavidyalaya And Research Centre Belagavi 
Address  KAHERs Shri B M Kankanwadi Ayurveda Mahavidyalaya And Research Centre Shahapur Belagavi karnataka 590003

Belgaum
KARNATAKA
590003
India 
Phone  8600060490  
Fax    
Email  patilshraddha1798@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Suhaskumar Shetty 
Designation  Professor Department of Kayachikitsa  
Affiliation  KAHERs Shri B M Kankanwadi Ayurveda Mahavidyalaya And Research Centre Belagavi 
Address  KAHERs Shri B M Kankanwadi Ayurveda Mahavidyalaya And Research Centre Shahapur Belagavi karnataka 590003

Belgaum
KARNATAKA
590003
India 
Phone  9449603234  
Fax    
Email  drsuhasshetty@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Suhaskumar Shetty 
Designation  Professor Department of Kayachikitsa  
Affiliation  KAHERs Shri B M Kankanwadi Ayurveda Mahavidyalaya And Research Centre Belagavi 
Address  KAHERs Shri B M Kankanwadi Ayurveda Mahavidyalaya And Research Centre Shahapur Belagavi karnataka 590003

Belgaum
KARNATAKA
590003
India 
Phone  9449603234  
Fax    
Email  drsuhasshetty@gmail.com  
 
Source of Monetary or Material Support  
KAHERS SHRI BMK AYURVEDA MAHAVIDYALAYA AND RESEARCH CENTRE Shahapur Belagavi Karnataka 
 
Primary Sponsor  
Name  Dr Patil Shraddha Anilrao 
Address  KAHERs Shri B M Kankanwadi Ayurveda Mahavidyalaya And Research Centre Shahapur Belagavi Karnataka 590003 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Patil Shraddha Anilrao  KAHERS Shri B.M.Kankanwadi Ayurveda Mahavidyalaya college And Research centre Shahapur Belagavi  OPD NO 6,7,3,21 Department of Kayachikitsa
Belgaum
KARNATAKA 
8600060490

patilshraddha1798@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee for Research on Human Subjects KAHERs Shri B M Kankanwadi Ayurveda Mahavidyala and KLE Ayurveda Hospital Shahapur Belagavi  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:R730||Abnormal glucose. Ayurveda Condition: PRAMEHA-PURVARUPAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Haridra, Reference: Sastry JLN, illustrated dravyaguna vijnyana 2nd edition, 2nd vol. haridra,Varanasi,chaukhambha orientalia. 2005.p.513-518, Route: Oral, Dosage Form: Churna/ Powder, Dose: 1.5(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 90 Days, anupAna/sahapAna: Yes(details: -warm water), Additional Information: -churna will be filled in capsules of 500mg, 3 capsules wiill be adviced to subject twice a day with warm water
2Intervention ArmDrugClassical(1) Medicine Name: Haritaki, Reference: Sastry JLN, illustrated dravyaguna vijnyana 2nd edition, 2nd vol. haritaki,Varanasi,chaukhambha orientalia. 2005.p.205-208, Route: Oral, Dosage Form: Churna/ Powder, Dose: 1.5(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 90 Days, anupAna/sahapAna: Yes(details: - warm water), Additional Information: -churna will be filled in capsules of 500mg, 3 capsules wiill be adviced to subject twice a day with warm water
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Individuals of HbA1c level between 5.7 to 6.4% 
 
ExclusionCriteria 
Details  1.Prediabetes with other systemic conditions like thyroid dysfunction, uncontrolled hypertension with or without medication (more than or equal to 140/90 mmHg).
2.Pregnant and lactating women.
3.Individuals on medication for longer period like glucocorticosteroids, thyroid hormones, pentamidine, nicotinic acid, antipsychotics, thiazides, β-adrenergic agonists.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
changes in Levels of HbA1c, FBS PPBS  subjective parameters will be assessed on
baseline on 0th 30th 60th 90th, day of the intervention. 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in QOL  subjective parameters will be assessed on
baseline on 0th 30th 60th 90th, day of the intervention. 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   01/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary    A randomized,double blind control clinical , parallel group, single center triall comparing efficacy of capsule Haritaki churna 1.5gms twice a day with warm water and capsule haridra churna 1.5gms twice a day with warm water daily for 90 days in 40 patients with Prediabetes will be conducted in KAHERS SHRI BMK AYURVEDA MAHAVIDYALAYA AND RESEARCH CENTRE Shahapur Belagavi Karnataka. The primary outcome will be haritaki churna may help in level of HbA1c, FBS and PPBS of prediabetic subjects and help in improving the QOL. 
Close